Darien Woman With Terminal Cervical Cancer Wins $49 Million Verdict Against Doctor Who Ignored HPV Warning Signs
A jury awarded $49 million to a Darien woman with terminal cervical cancer who sued her doctor for failing to follow up on high-risk HPV results.
A Connecticut jury has awarded $49 million to a Darien woman diagnosed with terminal cervical cancer after finding that her doctor failed to act on high-risk HPV test results that could have led to an earlier, potentially life-saving diagnosis.
The plaintiff, a resident of Darien, sued her physician for medical negligence, alleging that the doctor did not follow up on abnormal HPV findings that are widely recognized as a critical warning sign for cervical cancer. Attorneys for the woman argued that timely intervention following those results could have caught the cancer at a treatable stage.
Cervical cancer, when detected early, has a high survival rate. Medical guidelines recommend that patients who test positive for high-risk strains of HPV undergo additional screening and monitoring. Failure to adhere to those protocols, the plaintiff's legal team contended, directly contributed to her terminal diagnosis.
The $49 million verdict is one of the largest medical malpractice awards in Connecticut in recent years. It includes compensation for pain and suffering, loss of future earnings, and medical expenses associated with her ongoing treatment.
Defense attorneys argued that the physician followed an appropriate standard of care, but the jury sided with the plaintiff after deliberations. The verdict underscores growing scrutiny of how physicians manage and communicate follow-up care for patients with abnormal cancer screening results.
The case has drawn attention from patient advocacy groups, who say it highlights systemic gaps in follow-up protocols within primary care settings. Experts in gynecologic oncology note that missed or delayed follow-up on HPV results remains a persistent and preventable cause of late-stage cervical cancer diagnoses.
The woman's legal team said she hopes the verdict sends a clear message to the medical community about the life-or-death consequences of failing to act on high-risk screening results. Her condition remains terminal, and she continues to receive palliative treatment.